Acacia Diversified Holdings, Inc.
Acacia Diversified Holdings, Inc. ACCA Peers
See (ACCA) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACCA | $0.00 | N/A | 5428.00 | -0.00 | -$0.03 | N/A |
| MKKGY | $28.44 | +2.01% | 61.69B | 19.61 | $1.45 | +1.34% |
| MKGAF | $137.80 | -3.06% | 59.91B | 19.09 | $7.22 | +1.63% |
| HLNCF | $5.10 | -4.67% | 46.01B | 24.29 | $0.21 | +2.05% |
| TKPHF | $28.90 | +3.44% | 45.48B | 32.11 | $0.90 | +4.60% |
| IPSEY | $29.20 | +4.17% | 38.64B | 24.13 | $1.21 | +1.08% |
| SDZNY | $45.05 | +0.42% | 19.40B | -2252.50 | -$0.02 | +0.91% |
| TEVJF | $16.11 | -9.49% | 18.46B | -14.01 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.64B | 20.54 | $3.00 | N/A |
| SGIOY | $8.49 | +2.41% | 14.44B | 12.48 | $0.68 | +0.94% |
Stock Comparison
ACCA vs MKKGY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, MKKGY has a market cap of 61.69B. Regarding current trading prices, ACCA is priced at $0.00, while MKKGY trades at $28.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas MKKGY's P/E ratio is 19.61. In terms of profitability, ACCA's ROE is +0.00%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, ACCA is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs MKGAF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, MKGAF has a market cap of 59.91B. Regarding current trading prices, ACCA is priced at $0.00, while MKGAF trades at $137.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas MKGAF's P/E ratio is 19.09. In terms of profitability, ACCA's ROE is +0.00%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, ACCA is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs HLNCF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, HLNCF has a market cap of 46.01B. Regarding current trading prices, ACCA is priced at $0.00, while HLNCF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas HLNCF's P/E ratio is 24.29. In terms of profitability, ACCA's ROE is +0.00%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, ACCA is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs TKPHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, TKPHF has a market cap of 45.48B. Regarding current trading prices, ACCA is priced at $0.00, while TKPHF trades at $28.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas TKPHF's P/E ratio is 32.11. In terms of profitability, ACCA's ROE is +0.00%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, ACCA and TKPHF have similar daily volatility (0.00).
ACCA vs IPSEY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, IPSEY has a market cap of 38.64B. Regarding current trading prices, ACCA is priced at $0.00, while IPSEY trades at $29.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas IPSEY's P/E ratio is 24.13. In terms of profitability, ACCA's ROE is +0.00%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, ACCA and IPSEY have similar daily volatility (0.00).
ACCA vs SDZNY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, SDZNY has a market cap of 19.40B. Regarding current trading prices, ACCA is priced at $0.00, while SDZNY trades at $45.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas SDZNY's P/E ratio is -2252.50. In terms of profitability, ACCA's ROE is +0.00%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, ACCA is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs TEVJF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, TEVJF has a market cap of 18.46B. Regarding current trading prices, ACCA is priced at $0.00, while TEVJF trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas TEVJF's P/E ratio is -14.01. In terms of profitability, ACCA's ROE is +0.00%, compared to TEVJF's ROE of -0.26%. Regarding short-term risk, ACCA and TEVJF have similar daily volatility (0.00).
ACCA vs ESALY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, ESALY has a market cap of 17.64B. Regarding current trading prices, ACCA is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas ESALY's P/E ratio is 20.54. In terms of profitability, ACCA's ROE is +0.00%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, ACCA is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs SGIOY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, SGIOY has a market cap of 14.44B. Regarding current trading prices, ACCA is priced at $0.00, while SGIOY trades at $8.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas SGIOY's P/E ratio is 12.48. In terms of profitability, ACCA's ROE is +0.00%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, ACCA is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs SGIOF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, SGIOF has a market cap of 12.93B. Regarding current trading prices, ACCA is priced at $0.00, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas SGIOF's P/E ratio is 10.94. In terms of profitability, ACCA's ROE is +0.00%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, ACCA and SGIOF have similar daily volatility (0.00).
ACCA vs BIOVF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, BIOVF has a market cap of 10.48B. Regarding current trading prices, ACCA is priced at $0.00, while BIOVF trades at $30.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas BIOVF's P/E ratio is 25.85. In terms of profitability, ACCA's ROE is +0.00%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, ACCA is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs IPSEF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, IPSEF has a market cap of 10.37B. Regarding current trading prices, ACCA is priced at $0.00, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas IPSEF's P/E ratio is 25.96. In terms of profitability, ACCA's ROE is +0.00%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, ACCA is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs SFOSF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, SFOSF has a market cap of 8.62B. Regarding current trading prices, ACCA is priced at $0.00, while SFOSF trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas SFOSF's P/E ratio is 12.97. In terms of profitability, ACCA's ROE is +0.00%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, ACCA is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs ESAIY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, ESAIY has a market cap of 7.67B. Regarding current trading prices, ACCA is priced at $0.00, while ESAIY trades at $6.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas ESAIY's P/E ratio is 18.72. In terms of profitability, ACCA's ROE is +0.00%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, ACCA is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs ESALF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, ESALF has a market cap of 7.05B. Regarding current trading prices, ACCA is priced at $0.00, while ESALF trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas ESALF's P/E ratio is 17.36. In terms of profitability, ACCA's ROE is +0.00%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, ACCA is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs GZPHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, GZPHF has a market cap of 6.27B. Regarding current trading prices, ACCA is priced at $0.00, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, ACCA's ROE is +0.00%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, ACCA and GZPHF have similar daily volatility (0.00).
ACCA vs HKMPF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, HKMPF has a market cap of 5.94B. Regarding current trading prices, ACCA is priced at $0.00, while HKMPF trades at $26.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas HKMPF's P/E ratio is 16.73. In terms of profitability, ACCA's ROE is +0.00%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, ACCA is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs HKMPY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, HKMPY has a market cap of 5.93B. Regarding current trading prices, ACCA is priced at $0.00, while HKMPY trades at $53.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas HKMPY's P/E ratio is 16.70. In terms of profitability, ACCA's ROE is +0.00%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, ACCA is less volatile compared to HKMPY. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs APNHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, APNHF has a market cap of 5.44B. Regarding current trading prices, ACCA is priced at $0.00, while APNHF trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas APNHF's P/E ratio is 20.07. In terms of profitability, ACCA's ROE is +0.00%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, ACCA is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs WIBFF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, WIBFF has a market cap of 4.92B. Regarding current trading prices, ACCA is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, ACCA's ROE is +0.00%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, ACCA is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs LVZPF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, LVZPF has a market cap of 4.06B. Regarding current trading prices, ACCA is priced at $0.00, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, ACCA's ROE is +0.00%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, ACCA is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs HLBBF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, HLBBF has a market cap of 4.04B. Regarding current trading prices, ACCA is priced at $0.00, while HLBBF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas HLBBF's P/E ratio is 10.62. In terms of profitability, ACCA's ROE is +0.00%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, ACCA is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs HLUBF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, HLUBF has a market cap of 3.37B. Regarding current trading prices, ACCA is priced at $0.00, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas HLUBF's P/E ratio is 7.71. In terms of profitability, ACCA's ROE is +0.00%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, ACCA is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs APNHY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, APNHY has a market cap of 3.05B. Regarding current trading prices, ACCA is priced at $0.00, while APNHY trades at $6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas APNHY's P/E ratio is 12.47. In terms of profitability, ACCA's ROE is +0.00%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, ACCA is less volatile compared to APNHY. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs INVVY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, INVVY has a market cap of 3.01B. Regarding current trading prices, ACCA is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas INVVY's P/E ratio is -62.42. In terms of profitability, ACCA's ROE is +0.00%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, ACCA and INVVY have similar daily volatility (0.00).
ACCA vs IZQVF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, IZQVF has a market cap of 2.89B. Regarding current trading prices, ACCA is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, ACCA's ROE is +0.00%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, ACCA and IZQVF have similar daily volatility (0.00).
ACCA vs HMDCF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, HMDCF has a market cap of 2.79B. Regarding current trading prices, ACCA is priced at $0.00, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, ACCA's ROE is +0.00%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, ACCA is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs DNPUF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, DNPUF has a market cap of 2.59B. Regarding current trading prices, ACCA is priced at $0.00, while DNPUF trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas DNPUF's P/E ratio is -2.12. In terms of profitability, ACCA's ROE is +0.00%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, ACCA is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs ULIHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, ULIHF has a market cap of 2.54B. Regarding current trading prices, ACCA is priced at $0.00, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, ACCA's ROE is +0.00%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, ACCA is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs HYPMY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, HYPMY has a market cap of 2.51B. Regarding current trading prices, ACCA is priced at $0.00, while HYPMY trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas HYPMY's P/E ratio is 18.05. In terms of profitability, ACCA's ROE is +0.00%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, ACCA is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs HTSUF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, HTSUF has a market cap of 2.36B. Regarding current trading prices, ACCA is priced at $0.00, while HTSUF trades at $32.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas HTSUF's P/E ratio is 15.68. In terms of profitability, ACCA's ROE is +0.00%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, ACCA is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs THCBF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, THCBF has a market cap of 2.34B. Regarding current trading prices, ACCA is priced at $0.00, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas THCBF's P/E ratio is -0.10. In terms of profitability, ACCA's ROE is +0.00%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, ACCA is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs CHSYF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, CHSYF has a market cap of 2.25B. Regarding current trading prices, ACCA is priced at $0.00, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, ACCA's ROE is +0.00%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, ACCA and CHSYF have similar daily volatility (0.00).
ACCA vs TSMRF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, TSMRF has a market cap of 2.13B. Regarding current trading prices, ACCA is priced at $0.00, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, ACCA's ROE is +0.00%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, ACCA and TSMRF have similar daily volatility (0.00).
ACCA vs DMPHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, DMPHF has a market cap of 2.13B. Regarding current trading prices, ACCA is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas DMPHF's P/E ratio is 16.55. In terms of profitability, ACCA's ROE is +0.00%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, ACCA and DMPHF have similar daily volatility (0.00).
ACCA vs LJUIF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, LJUIF has a market cap of 2.06B. Regarding current trading prices, ACCA is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, ACCA's ROE is +0.00%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, ACCA and LJUIF have similar daily volatility (0.00).
ACCA vs LBTSF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, LBTSF has a market cap of 1.92B. Regarding current trading prices, ACCA is priced at $0.00, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, ACCA's ROE is +0.00%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, ACCA is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs NPNKF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, NPNKF has a market cap of 1.77B. Regarding current trading prices, ACCA is priced at $0.00, while NPNKF trades at $26.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas NPNKF's P/E ratio is 8.35. In terms of profitability, ACCA's ROE is +0.00%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, ACCA is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs SHEZF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, SHEZF has a market cap of 1.69B. Regarding current trading prices, ACCA is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, ACCA's ROE is +0.00%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, ACCA is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs CHIZF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, CHIZF has a market cap of 1.69B. Regarding current trading prices, ACCA is priced at $0.00, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, ACCA's ROE is +0.00%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, ACCA and CHIZF have similar daily volatility (0.00).
ACCA vs SMDPY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, SMDPY has a market cap of 1.63B. Regarding current trading prices, ACCA is priced at $0.00, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas SMDPY's P/E ratio is -1.32. In terms of profitability, ACCA's ROE is +0.00%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, ACCA and SMDPY have similar daily volatility (0.00).
ACCA vs AUSAF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, AUSAF has a market cap of 1.57B. Regarding current trading prices, ACCA is priced at $0.00, while AUSAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas AUSAF's P/E ratio is N/A. In terms of profitability, ACCA's ROE is +0.00%, compared to AUSAF's ROE of -1.15%. Regarding short-term risk, ACCA is less volatile compared to AUSAF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs NPPNY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, NPPNY has a market cap of 1.57B. Regarding current trading prices, ACCA is priced at $0.00, while NPPNY trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas NPPNY's P/E ratio is 7.35. In terms of profitability, ACCA's ROE is +0.00%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, ACCA and NPPNY have similar daily volatility (0.00).
ACCA vs KARBF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, KARBF has a market cap of 1.52B. Regarding current trading prices, ACCA is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas KARBF's P/E ratio is 262.50. In terms of profitability, ACCA's ROE is +0.00%, compared to KARBF's ROE of N/A. Regarding short-term risk, ACCA and KARBF have similar daily volatility (0.00).
ACCA vs YIHCF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, YIHCF has a market cap of 1.47B. Regarding current trading prices, ACCA is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, ACCA's ROE is +0.00%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, ACCA and YIHCF have similar daily volatility (0.00).
ACCA vs EVOTF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, EVOTF has a market cap of 1.47B. Regarding current trading prices, ACCA is priced at $0.00, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, ACCA's ROE is +0.00%, compared to EVOTF's ROE of -0.19%. Regarding short-term risk, ACCA is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs ARSUF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, ARSUF has a market cap of 1.46B. Regarding current trading prices, ACCA is priced at $0.00, while ARSUF trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas ARSUF's P/E ratio is 18.05. In terms of profitability, ACCA's ROE is +0.00%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, ACCA is less volatile compared to ARSUF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs GTBIF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, GTBIF has a market cap of 1.31B. Regarding current trading prices, ACCA is priced at $0.00, while GTBIF trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas GTBIF's P/E ratio is 18.36. In terms of profitability, ACCA's ROE is +0.00%, compared to GTBIF's ROE of +0.04%. Regarding short-term risk, ACCA is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs SWGHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, SWGHF has a market cap of 1.15B. Regarding current trading prices, ACCA is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas SWGHF's P/E ratio is 13.71. In terms of profitability, ACCA's ROE is +0.00%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, ACCA and SWGHF have similar daily volatility (0.00).
ACCA vs BIOGY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, BIOGY has a market cap of 1.12B. Regarding current trading prices, ACCA is priced at $0.00, while BIOGY trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas BIOGY's P/E ratio is 33.78. In terms of profitability, ACCA's ROE is +0.00%, compared to BIOGY's ROE of +0.20%. Regarding short-term risk, ACCA is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs GNMLF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, GNMLF has a market cap of 1.09B. Regarding current trading prices, ACCA is priced at $0.00, while GNMLF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas GNMLF's P/E ratio is 9.91. In terms of profitability, ACCA's ROE is +0.00%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, ACCA and GNMLF have similar daily volatility (0.00).
ACCA vs NIKA Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, NIKA has a market cap of 1.03B. Regarding current trading prices, ACCA is priced at $0.00, while NIKA trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas NIKA's P/E ratio is N/A. In terms of profitability, ACCA's ROE is +0.00%, compared to NIKA's ROE of +0.63%. Regarding short-term risk, ACCA and NIKA have similar daily volatility (0.00).
ACCA vs KKPCF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, KKPCF has a market cap of 1.01B. Regarding current trading prices, ACCA is priced at $0.00, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas KKPCF's P/E ratio is 7.10. In terms of profitability, ACCA's ROE is +0.00%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, ACCA is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs KSPHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, KSPHF has a market cap of 994.32M. Regarding current trading prices, ACCA is priced at $0.00, while KSPHF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas KSPHF's P/E ratio is 12.16. In terms of profitability, ACCA's ROE is +0.00%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, ACCA is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs CASBF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, CASBF has a market cap of 984.67M. Regarding current trading prices, ACCA is priced at $0.00, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas CASBF's P/E ratio is -15.24. In terms of profitability, ACCA's ROE is +0.00%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, ACCA is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs LVTTF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, LVTTF has a market cap of 880.16M. Regarding current trading prices, ACCA is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, ACCA's ROE is +0.00%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, ACCA is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs EVRRF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, EVRRF has a market cap of 873.78M. Regarding current trading prices, ACCA is priced at $0.00, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, ACCA's ROE is +0.00%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, ACCA and EVRRF have similar daily volatility (0.00).
ACCA vs TCNNF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, TCNNF has a market cap of 857.99M. Regarding current trading prices, ACCA is priced at $0.00, while TCNNF trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas TCNNF's P/E ratio is -5.67. In terms of profitability, ACCA's ROE is +0.00%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, ACCA is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs NRXCF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, NRXCF has a market cap of 829.09M. Regarding current trading prices, ACCA is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, ACCA's ROE is +0.00%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, ACCA and NRXCF have similar daily volatility (0.00).
ACCA vs TWAPF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, TWAPF has a market cap of 828.49M. Regarding current trading prices, ACCA is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas TWAPF's P/E ratio is 6.16. In terms of profitability, ACCA's ROE is +0.00%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, ACCA and TWAPF have similar daily volatility (0.00).
ACCA vs CSWYF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, CSWYF has a market cap of 815.83M. Regarding current trading prices, ACCA is priced at $0.00, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, ACCA's ROE is +0.00%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, ACCA is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs TRXPF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, TRXPF has a market cap of 690.69M. Regarding current trading prices, ACCA is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, ACCA's ROE is +0.00%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, ACCA and TRXPF have similar daily volatility (0.00).
ACCA vs SWDCF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, SWDCF has a market cap of 679.32M. Regarding current trading prices, ACCA is priced at $0.00, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, ACCA's ROE is +0.00%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, ACCA is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs CURLF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, CURLF has a market cap of 653.58M. Regarding current trading prices, ACCA is priced at $0.00, while CURLF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas CURLF's P/E ratio is -2.79. In terms of profitability, ACCA's ROE is +0.00%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, ACCA is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs TRSSF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, TRSSF has a market cap of 601.91M. Regarding current trading prices, ACCA is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, ACCA's ROE is +0.00%, compared to TRSSF's ROE of -0.43%. Regarding short-term risk, ACCA is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs SGFEF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, SGFEF has a market cap of 544.13M. Regarding current trading prices, ACCA is priced at $0.00, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas SGFEF's P/E ratio is 22.83. In terms of profitability, ACCA's ROE is +0.00%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, ACCA is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs CCHWF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, CCHWF has a market cap of 521.35M. Regarding current trading prices, ACCA is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, ACCA's ROE is +0.00%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, ACCA is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs AIHLF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, AIHLF has a market cap of 507.80M. Regarding current trading prices, ACCA is priced at $0.00, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, ACCA's ROE is +0.00%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, ACCA is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs BOIRF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, BOIRF has a market cap of 494.82M. Regarding current trading prices, ACCA is priced at $0.00, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, ACCA's ROE is +0.00%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, ACCA is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs PEXXF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, PEXXF has a market cap of 463.12M. Regarding current trading prices, ACCA is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, ACCA's ROE is +0.00%, compared to PEXXF's ROE of N/A. Regarding short-term risk, ACCA and PEXXF have similar daily volatility (0.00).
ACCA vs ELTP Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, ELTP has a market cap of 459.36M. Regarding current trading prices, ACCA is priced at $0.00, while ELTP trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas ELTP's P/E ratio is -21.50. In terms of profitability, ACCA's ROE is +0.00%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, ACCA is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs SHPHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, SHPHF has a market cap of 455.30M. Regarding current trading prices, ACCA is priced at $0.00, while SHPHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas SHPHF's P/E ratio is -1.64. In terms of profitability, ACCA's ROE is +0.00%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, ACCA is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs MITPF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, MITPF has a market cap of 451.63M. Regarding current trading prices, ACCA is priced at $0.00, while MITPF trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas MITPF's P/E ratio is -3.05. In terms of profitability, ACCA's ROE is +0.00%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, ACCA and MITPF have similar daily volatility (0.00).
ACCA vs KHTRF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, KHTRF has a market cap of 443.54M. Regarding current trading prices, ACCA is priced at $0.00, while KHTRF trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas KHTRF's P/E ratio is 148.67. In terms of profitability, ACCA's ROE is +0.00%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, ACCA is less volatile compared to KHTRF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs AGYTF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, AGYTF has a market cap of 405.15M. Regarding current trading prices, ACCA is priced at $0.00, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, ACCA's ROE is +0.00%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, ACCA is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs GLASF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, GLASF has a market cap of 314.01M. Regarding current trading prices, ACCA is priced at $0.00, while GLASF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas GLASF's P/E ratio is -30.00. In terms of profitability, ACCA's ROE is +0.00%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, ACCA is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs PKBFF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, PKBFF has a market cap of 288.49M. Regarding current trading prices, ACCA is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, ACCA's ROE is +0.00%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, ACCA is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs BHCCF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, BHCCF has a market cap of 271.24M. Regarding current trading prices, ACCA is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, ACCA's ROE is +0.00%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, ACCA is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs VRNOF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, VRNOF has a market cap of 259.00M. Regarding current trading prices, ACCA is priced at $0.00, while VRNOF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas VRNOF's P/E ratio is -0.73. In terms of profitability, ACCA's ROE is +0.00%, compared to VRNOF's ROE of -0.24%. Regarding short-term risk, ACCA is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs CRLBF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, CRLBF has a market cap of 240.87M. Regarding current trading prices, ACCA is priced at $0.00, while CRLBF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas CRLBF's P/E ratio is -3.25. In terms of profitability, ACCA's ROE is +0.00%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, ACCA is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs CPHRF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, CPHRF has a market cap of 237.44M. Regarding current trading prices, ACCA is priced at $0.00, while CPHRF trades at $9.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas CPHRF's P/E ratio is 20.15. In terms of profitability, ACCA's ROE is +0.00%, compared to CPHRF's ROE of +0.12%. Regarding short-term risk, ACCA is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs PLNHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, PLNHF has a market cap of 202.02M. Regarding current trading prices, ACCA is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, ACCA's ROE is +0.00%, compared to PLNHF's ROE of +0.01%. Regarding short-term risk, ACCA is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs HUMDF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, HUMDF has a market cap of 147.55M. Regarding current trading prices, ACCA is priced at $0.00, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, ACCA's ROE is +0.00%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, ACCA and HUMDF have similar daily volatility (0.00).
ACCA vs COPHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, COPHF has a market cap of 131.72M. Regarding current trading prices, ACCA is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas COPHF's P/E ratio is -0.02. In terms of profitability, ACCA's ROE is +0.00%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, ACCA is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs PHCUF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, PHCUF has a market cap of 117.10M. Regarding current trading prices, ACCA is priced at $0.00, while PHCUF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas PHCUF's P/E ratio is -432.00. In terms of profitability, ACCA's ROE is +0.00%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, ACCA is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs LPCUF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, LPCUF has a market cap of 110.82M. Regarding current trading prices, ACCA is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, ACCA's ROE is +0.00%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, ACCA and LPCUF have similar daily volatility (0.00).
ACCA vs CNVCF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, CNVCF has a market cap of 109.16M. Regarding current trading prices, ACCA is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, ACCA's ROE is +0.00%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, ACCA and CNVCF have similar daily volatility (0.00).
ACCA vs GRUSF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, GRUSF has a market cap of 107.69M. Regarding current trading prices, ACCA is priced at $0.00, while GRUSF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas GRUSF's P/E ratio is -8.69. In terms of profitability, ACCA's ROE is +0.00%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, ACCA is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs HLTRF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, HLTRF has a market cap of 102.37M. Regarding current trading prices, ACCA is priced at $0.00, while HLTRF trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas HLTRF's P/E ratio is -5.19. In terms of profitability, ACCA's ROE is +0.00%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, ACCA is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs ABSCF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, ABSCF has a market cap of 92.53M. Regarding current trading prices, ACCA is priced at $0.00, while ABSCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas ABSCF's P/E ratio is -20.00. In terms of profitability, ACCA's ROE is +0.00%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, ACCA is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs PLNH Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, PLNH has a market cap of 88.93M. Regarding current trading prices, ACCA is priced at $0.00, while PLNH trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas PLNH's P/E ratio is -1.71. In terms of profitability, ACCA's ROE is +0.00%, compared to PLNH's ROE of -0.36%. Regarding short-term risk, ACCA is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs BIOYF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, BIOYF has a market cap of 88.33M. Regarding current trading prices, ACCA is priced at $0.00, while BIOYF trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas BIOYF's P/E ratio is 17.11. In terms of profitability, ACCA's ROE is +0.00%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, ACCA is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs LOVFF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, LOVFF has a market cap of 84.71M. Regarding current trading prices, ACCA is priced at $0.00, while LOVFF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas LOVFF's P/E ratio is 9.34. In terms of profitability, ACCA's ROE is +0.00%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, ACCA is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs GBLP Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, GBLP has a market cap of 83.54M. Regarding current trading prices, ACCA is priced at $0.00, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas GBLP's P/E ratio is -0.67. In terms of profitability, ACCA's ROE is +0.00%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, ACCA is less volatile compared to GBLP. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs LRDSF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, LRDSF has a market cap of 82.83M. Regarding current trading prices, ACCA is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, ACCA's ROE is +0.00%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, ACCA is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs CBWTF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, CBWTF has a market cap of 80.69M. Regarding current trading prices, ACCA is priced at $0.00, while CBWTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas CBWTF's P/E ratio is -6.14. In terms of profitability, ACCA's ROE is +0.00%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, ACCA is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs EOFBY Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, EOFBY has a market cap of 73.67M. Regarding current trading prices, ACCA is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, ACCA's ROE is +0.00%, compared to EOFBY's ROE of N/A. Regarding short-term risk, ACCA and EOFBY have similar daily volatility (0.00).
ACCA vs AAWH Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, AAWH has a market cap of 70.80M. Regarding current trading prices, ACCA is priced at $0.00, while AAWH trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas AAWH's P/E ratio is -0.86. In terms of profitability, ACCA's ROE is +0.00%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, ACCA is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.
ACCA vs JUSHF Comparison
ACCA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACCA stands at 5428.00. In comparison, JUSHF has a market cap of 67.57M. Regarding current trading prices, ACCA is priced at $0.00, while JUSHF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACCA currently has a P/E ratio of -0.00, whereas JUSHF's P/E ratio is -1.37. In terms of profitability, ACCA's ROE is +0.00%, compared to JUSHF's ROE of +1.44%. Regarding short-term risk, ACCA is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACCA.